About
Aptissen SA is a Swiss company founded in 2013, focused on the research, development, manufacturing, and commercialization of biopolymer-based medical devices and orthobiologic solutions for musculoskeletal health and joint disorders. Originating as a spin-off from Anteis SA, the company leverages over a decade of expertise in advanced polymers for tissue engineering. Aptissen's flagship product, Synolis™, is a patented injectable gel that combines Hyaluronic Acid and Sorbitol to alleviate pain associated with osteoarthritis. Additionally, the company offers Cartylis™, a drinkable food supplement that promotes collagen synthesis to enhance joint function. Their product portfolio also includes solutions for ophthalmology and orthopaedics, emphasizing patient benefits and quality of life improvements. Aptissen is ISO 13485:2016 certified and operates a global distribution network across over 50 countries, with subsidiaries in Italy, Poland, France, and Germany. The company actively seeks partnerships to expand its market reach and product offerings.
Technologies
Keywords
Company Information
-
Employees 51
-
Founded 2013
Location
36 Chemin du Champ-des-Filles, Plan-les-Ouates, Geneva, Switzerland, 1228